Résumé (EN)

This chapter examines the politics of transparency through the case of a government website that discloses the potential conflicts of interest (COIs) between pharmaceutical companies and health professionals. Since the late 2000s, several US and European initiatives have endeavored to meet the objective of transparency by putting together large publicly accessible databases that promise to prevent undue influence and misdemeanor by recording, classifying, and disclosing millions of transactions between firms and health professionals. France's Transparence Santé (Transparency in Healthcare) database, officially launched in 2014, is one of the first examples of these new tools. In the aftermath of a major public health scandal, disclosing all financial interests was seen as an obvious response. This chapter draws on interviews, observations, and analysis